SPL UNCLASSIFIED SECTION
Drug Facts
Drug Facts
Active ingredients (in each 5 mL tsp.)
Guaifenesin 200 mg
Phenylephrine HCl 5 mg
Purpose
Guaifenesin .....................Expectorant
Phenylephrine ........Nasal Decongestant
Uses • helps loosen phlegm (mucus) and thin bronchial secretions to drain
bronchial tubes • temporarily relieves nasal congestion due to the common cold.
Warnings: • Do not exceed recommended dosage •
If nervousness,
dizziness, or sleeplessness occurs, discontinue use and consult a
doctor.
Do not use this product • for persistant or chronic cough, such as
occurs with smoking, asthma, chronic bronchitis, or emphysema, or if
cough is accompanied by excessive phlegm (mucus), unless directed
by a Doctor • if you are now taking a prescription Monoamineoxidase
Inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional
conditions, or Parkinson's disease), or for 2 weeks after stopping the
MAOI drug. If you do not know if you are taking a prescription drug that
contains an MAOI, ask a doctor or a pharmacist before taking this product.
• if you have heart disease, high blood pressure, thyroid disease, diabetes,
or difficulty in urination due to enlargement of the prostate gland unless
directed by a Doctor.
Stop use and ask a Doctor • A persistent cough may be a sign of a
serious condition; • If cough persists for more than one week, tend to
recur, or is accompanied by fever, rash or persistent headache; • if
symptoms do not improve within 7 days or are accompanied by fever.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, contact a physician or Poison Control Center right away.
Directions Do not exceed more than 6 doses for children and adults
in a 24 - hour period.
Adults and Children 12 years of age and over | 2 teaspoonfuls (10 mL) every 4 hours |
Children 6 to under 12 years of age | 1 teaspoonful (5 mL) every 4 hours |
| Children under 6 years of age | Ask a doctor |
Other information • Store at room temperature 15º-30ºC (59º-86ºF).
Tamper evident: Do not use if there is evidence of tampering.
Inactive ingredients: citric acid, glycerin, garpe flavor, methylparaben
(as preservative), propylene glycol, propylparaben (as preservative),
purified water, sodium citrate, sucralose, xanthan gum
Questions or Comments?
customer.service@lablopez.com.sv
NDC 76864-209-02
Baczol
®
EXPECTORANT
Guaifenesin • Expectorant
Phenylephrine HCl • Nasal Decongestant
Fruit Flavor
• Sugar FREE
• Alcohol FREE
4 fl. oz.
Manufactured For:
Laboratorios López, S.A. de C.V.
Boulevard del Ejército Nacional, Km. 5 1/2,
Soyapango, San Salvador,, El Salvador, C.A.
Lot: Rev. 07/2020
Exp. Date:
Carton
Bottle
res
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1370427 | guaiFENesin 200 MG / phenylephrine hydrochloride 5 MG in 5 mL Oral Solution | PSN | 5 |
| 1370427 | guaifenesin 40 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | SCD | 5 |
| 1370427 | guaifenesin 200 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution | SY | 5 |
| Class | Version | Type | Effective |
|---|---|---|---|
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e4e263da-1c53-440f-bb80-b7a575843b5a | Product name | 1 | 20260313 |
| d2168cac-a261-415a-9c78-3522859fa720 | Product name | 3 | 20251124 |
| 05a8cdd1-eeb8-409e-b938-0778225eca7d | Product name | 4 | 20250221 |
| e5b5c132-b15d-435b-9faa-2f74e5cadcf9 | Product name | 8 | 20250220 |
| f489e8f3-5c9e-4818-b539-a73587edcfc7 | Product name | 2 | 20240229 |
| 0f7ae452-206d-4fc4-868d-56fc47074084 | Product name | 1 | 20231011 |
| b5abe2e3-39a1-43eb-9bff-f3c1653fe3df | Product name | 2 | 20190930 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 42f3c020-f1b3-89bc-7bdc-e1f10e680485 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76864-209-02 | 2023-08-28 | C162847 | 48780-1 | f386c649-ca0e-0266-e053-dadaa90a7c1a | BACZOL EXPECTORANT (Lex) |
| 76864-209-02 | 2023-01-30 | C162847 | 48780-1 | f386c649-ca0e-0266-e053-dadaa90a7c1a | BACZOL EXPECTORANT (Lex) |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76864-209-02 | BACZOL EXPECTORANT | 120 mL in 1 BOTTLE, PLASTIC | SYRUP | 120 | 5 | |
| 76864-209-02 | BACZOL EXPECTORANT | 1 in 1 CARTON | SYRUP | 1 | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76864-209 | 76864-209-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| GUAIFENESIN | 495W7451VQ | ACTIB |
| PHENYLEPHRINE HYDROCHLORIDE | 04JA59TNSJ | ACTIM |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 570fafbd-dc2b-d737-e063-6394a90a7322 | 8e928b79-2178-47ef-8427-6bb57f143261 | 2026-07-20 | Warnings | 8e928b79-2178-47ef-8427-6bb57f143261 |
Adverse event summaries are temporarily unavailable. Other product information remains available.